The Swiss Biotech Day has long become the standard annual get-together of the Swiss biopharmaceutical industry. And Basel, as one of the most vivid cities in terms of biotechnological and pharmaceutical research, development and production, proved to be the ideal location.
Now in its 19th year, the SBD is not just the place to be for members of the Swiss Biotech Association, who traditionally meet there for the association’s Annual General Assembly. As always, the event targets entrepreneurs, investors, researchers, analysts, political decision makers and industry stakeholders. Attendees will be able to meet key stakeholders and friends via SBD’s partnering systems or enjoy presentations from key authorities like Richard Ridinger, the CEO of Lonza AG. See you in Basel!